Herbert Kim Lyerly MD

Kim Lyerly

Core Faculty

Herbert Kim Lyerly, MD

Tsao L-C, Crosby EJ, Trotter TN, Wei J, Wang T, Yang X, et al. Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis. Jci Insight. 2022 Mar 22;7(6).

Hwang B-J, Tsao L-C, Acharya CR, Trotter T, Agarwal P, Wei J, et al. Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. J Immunother Cancer. 2022 Mar;10(3).

Osada T, Crosby EJ, Kaneko K, Snyder JC, Ginzel JD, Acharya CR, et al. HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study. Mol Cancer Ther. 2022 Jan;21(1):217–26.